IP in India. State vs Pfizer. 1:0.

I have written that India plays very dangerous game regarding IP and price issues for pharmaceutical products. And the situation is developing really badly: patent for cancer drug sutent revoked by Pfizer.

It looks like Indian state just nationalized IP for sutent. If it is so – I just admire this extremely simple solution for very serious and complicated problem: India has very poor population and very rich company Pfizer can afford some charity. Why not? Another question: if this approach will be successful, what poor country will dare to repeat this approach? And why just sutent? There are more useful drugs on the market!